Skip to content

Pancreas Screening in High Risk Individuals

Pancreas Screening in High Risk Individuals: A Prospective Cohort

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07012018
Enrollment
2000
Registered
2025-06-10
Start date
2025-09-30
Completion date
2035-12-31
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Cancer Screening

Brief summary

Pancreas cancer is the 11th most common cancer in Canada but the 4th most common cause of cancer death because by the time pancreas cancer is detected, it is almost always too advanced for surgery. There are known factors that put individuals at higher risk for pancreas cancer. These include: certain genetic mutations, a family history of pancreas cancer, pancreas cysts and a new diagnosis of diabetes mellitus. Individuals with these risk factors are recommended to undergo pancreas screening with blood tests and yearly imaging tests of the pancreas. Our study will enroll patients with these risk factors and ensure they are managed as per guidelines. Prospectively collected data will include: patient clinicodemographic details, lifestyle factors, screening test results, clinical outcomes and patient reported outcome measures.

Interventions

None listed

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Family history of pancreatic cancer, pathogenic variant increasing risk of pancreatic cancer, IPMN, new onset diabetes.

Exclusion criteria

* Unable to give informed consnet

Design outcomes

Primary

MeasureTime frame
Incidence of pancreatic cancer10 years

Contacts

Primary ContactJennifer Telford, MD MPH
jtelford@telus.net1-604-688-6332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026